2013
DOI: 10.2174/157341313805117857
|View full text |Cite
|
Sign up to set email alerts
|

Nanotechnology-Based Drug Delivery Systems for Treatment of Hyperproliferative Skin Diseases - A Review

Abstract: The chronic hyperproliferative diseases (CHD) include cancer, precancerous lesions and diseases of unknown etiology such as psoriasis. Various drugs have been used in the treatment of CHD, such as antiproliferative and corticosteroids in general. However, some drugs have properties that limit their effectiveness, such as low solubility in water and low penetration of the skin. Thus, the control of drug release in the skin may improve efficacy and reduce side effects of many drugs used in hyperproliferative dis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 92 publications
(121 reference statements)
0
1
0
Order By: Relevance
“…Thus, the antioxidant effect of CNCs could protect hydroquinone in the CNC‐HDQ complex from oxidation . The HDQ‐CNC complex showed an approximately sustained release profile of HDQ over 4 h. The sustained delivery of therapeutic agent to skin using nanoparticles could improve the efficacy and reduce the side‐effects of these agents .…”
Section: Discussionmentioning
confidence: 99%
“…Thus, the antioxidant effect of CNCs could protect hydroquinone in the CNC‐HDQ complex from oxidation . The HDQ‐CNC complex showed an approximately sustained release profile of HDQ over 4 h. The sustained delivery of therapeutic agent to skin using nanoparticles could improve the efficacy and reduce the side‐effects of these agents .…”
Section: Discussionmentioning
confidence: 99%